|Leave a Message or Start an on-line Chat
The creation of the CSF2RB recombinant monoclonal antibody involves a meticulous and controlled process to ensure its exceptional quality and specificity. It begins by isolating B cells from an immunized animal using the recombinant human CSF2RB protein as the immunogen. Total RNA is extracted from these B cells and converted into cDNA through reverse transcription. The CSF2RB antibody genes are then amplified using specific primers targeting the antibody constant regions and inserted into an expression vector. Through transfection, the vector is introduced into host cells, enabling the production of the CSF2RB recombinant monoclonal antibody. After a period of cell culture, the antibody is collected from the supernatant and purified using affinity chromatography, resulting in a highly purified form suitable for various applications. To ensure its reliability and functionality, CUSABIO conducts ELISA to validate its specificity and effectiveness in detecting human CSF2RB protein.
There are currently no reviews for this product.